Lu Xiangyi’s six refrigerated centrifuges have been successfully shipped and their installation and commissioning have been completed.

Release time:

2019-11-14


Overview:

As Chinese people’s incomes rise and living standards improve, they are placing greater demands on and paying more attention to health and the quality of medical care. Among these, the production and application of syphilis reagin diagnostic reagents, hepatitis B surface antigen diagnostic reagents, and human immunodeficiency virus antibody test reagents—these diagnostic and testing agents—are directly linked to people’s health and well-being.


According to available data, diagnostic reagents refer to reagents prepared using principles or methods such as immunology, microbiology, and molecular biology, which are used in vitro for the diagnosis, detection, and epidemiological investigation of human diseases. Currently, China’s diagnostic reagent market is large, and it also boasts enormous potential for future growth.


Diagnostic reagents represent a simple, rapid, and easily accessible diagnostic technology suitable for widespread use and on-site testing. They are characterized by being independent of specific instrumentation, easy to operate, and capable of providing timely and accurate results. After years of development, the application scope of diagnostic reagents has been expanding, playing an increasingly significant role in disease prevention and post-treatment monitoring, and their commercial value continues to grow.


In recent years, amid the rapid development of the diagnostic and testing reagent industry in China, pharmaceutical companies have been required to strengthen their testing efforts and equip themselves with specialized testing instruments—including centrifuges—so as to better ensure the safety of their formulations. This trend has also brought new opportunities for manufacturers of related testing instruments, such as centrifuges.


Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. (hereinafter referred to as "Luxiangyi") recently signed an agreement to become the supplier for a certain biopharmaceutical company in Shanghai. Centrifuge The instrument supplier will provide the company with centrifuges that offer stable performance as well as excellent after-sales technical support services. On November 13, 2019, Lu Xiangyi delivered three units. GL21M High-Speed Refrigerated Centrifuge With 3 units GL12M Floor-Standing High-Speed Refrigerated Centrifuge It has been successfully shipped to the customer’s location and all installation and commissioning work has been completed.

Lu Xiangyi’s six-unit refrigerated centrifuge has been successfully shipped.


The two products delivered this time are the GL-21M high-speed refrigerated centrifuge and the GL-12M floor-standing high-speed refrigerated centrifuge. Among them, the GL-21M high-speed refrigerated centrifuge is specially designed for customers with high-speed requirements and can be widely used in fields such as clinical medicine, bioengineering, genetic engineering, pharmaceuticals, and higher education institutions.


The GL-21M high-speed refrigerated centrifuge can reach a maximum rotor speed of 21,000 rpm and a maximum relative centrifugal force of up to 50,400 x g. It is microcomputer-controlled and driven by a high-torque AC variable-frequency motor. The equipment features stable operation, low noise levels, and high rotational speed accuracy. It also utilizes an imported high-performance compressor unit and a fluorine-free refrigerant, R404a, meeting environmental protection standards. Furthermore, it employs an integral sealing ring made of food-grade silicone rubber, complying with GMP certification requirements. This centrifuge has now obtained FDA certification from the United States.


The GL-12M high-speed refrigerated centrifuge is specially designed for customers with high-speed and large-capacity requirements and can be widely used in fields such as clinical medicine, bioengineering, genetic engineering, and pharmaceuticals.


Its maximum rotational speed can reach 12,000 rpm, and its maximum capacity can go up to 2,000 ml × 4. The equipment is microcomputer-controlled and driven by a high-torque AC variable-frequency motor, ensuring stable operation, low noise, and high rotational speed accuracy. It features an imported high-performance compressor unit and uses the fluorine-free refrigerant R404a, meeting environmental protection requirements and delivering excellent cooling performance. The GL-12M model boasts a large-screen LCD display with a user-friendly interface, making operation simple and convenient. It offers 10 programmable ramp-up and ramp-down rate curves, allowing users to set the ramp-up and ramp-down times according to their needs. Equipped with an electronic door lock, it provides multiple protective functions, including door cover protection, overspeed protection, overtemperature protection, and imbalance detection. It also features an automatic alarm system for fault detection, ensuring safety and reliability. The centrifuge employs an integral sealing ring made of food-grade silicone rubber, compliant with GMP certification. This centrifuge has also obtained FDA certification from the United States.


For decades, Lu Xiangyi has remained steadfast in her commitment to advancing the quality and innovative development of domestically produced centrifuges. While ensuring top-notch quality, she has also designed numerous groundbreaking centrifuge models, filling many technological gaps. She continues to make her unique contributions to the development of generic and originator drugs within China’s pharmaceutical companies. Thanks to her unwavering focus on quality and innovation, Shanghai Lu Xiangyi’s centrifuges are now exported to over 30 countries, including the United States, Germany, the United Kingdom, Canada, and Thailand, earning widespread recognition and trust from both domestic and international customers. Upholding the production philosophy of “Quality First, Reputation Supreme,” Lu Xiangyi will continue to contribute to the safe production of pharmaceuticals and the advancement of human health in China!